Kiyotaka Yoh

Kiyotaka Yoh

UNVERIFIED PROFILE

Are you Kiyotaka Yoh?   Register this Author

Register author
Kiyotaka Yoh

Kiyotaka Yoh

Publications by authors named "Kiyotaka Yoh"

Are you Kiyotaka Yoh?   Register this Author

98Publications

2165Reads

6Profile Views

Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.

J Cancer Res Clin Oncol 2019 Oct 7;145(10):2495-2506. Epub 2019 Sep 7.

Department of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-019-03012-zDOI Listing
October 2019

Long-term results of S-1 plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer.

Cancer Chemother Pharmacol 2018 03 31;81(3):565-572. Epub 2018 Jan 31.

Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-018-3530-yDOI Listing
March 2018

Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Motesanib (AMG-706) in Combination With Paclitaxel and Carboplatin in East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.

J Clin Oncol 2017 Nov 13;35(32):3662-3670. Epub 2017 Sep 13.

Kaoru Kubota, Nippon Medical School; Kaori Hara and Takayuki Asato, Takeda Pharmaceutical, Tokyo; Hiroshige Yoshioka, Kurashiki Central Hospital, Kurashiki; Fumihiro Oshita, Kanagawa Prefectural Ashigarakami Hospital, Matsuda; Toyoaki Hida, Aichi Cancer Center Hospital, Nagoya; Kiyotaka Yoh, National Cancer Center Hospital East, Chiba; Hidetoshi Hayashi, Hiroyasu Kaneda, and Kazuhiko Nakagawa, Kindai University Faculty of Medicine; Hidetoshi Hayashi, Kishiwada Municipal Hospital, Osaka; Terufumi Kato, Kanagawa Cardiovascular and Respiratory Center, Yokohama; Kazuhiko Yamada, Kurume University School of Medicine; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hiroshi Tanaka, Niigata Cancer Center Hospital, Niigata, Japan; Keunchil Park, Samsung Biomedical Research Institute, Seoul; Eun Kyung Cho, Gachon University; Kyung-Hee Lee, Inha University Hospital, Incheon, South Korea; Chih-Bin Lin, Buddhist Tzu-Chi General Hospital, Hualien; James Chih-Hsin Yang, National Taiwan University Hospital; National Taiwan University Cancer Center, Taipei City, Peoples Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.7297DOI Listing
November 2017

Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases.

J Cancer Res Clin Oncol 2017 Jun 20;143(6):1075-1082. Epub 2017 Feb 20.

Department of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-0882, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00432-017-2350-5
Publisher Site
http://dx.doi.org/10.1007/s00432-017-2350-5DOI Listing
June 2017

Switch maintenance chemotherapy using S-1 with or without bevacizumab in patients with advanced non-small cell lung cancer: a phase II study.

Lung Cancer 2017 06 1;108:66-71. Epub 2017 Mar 1.

Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.02.018DOI Listing
June 2017

Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component.

J Clin Oncol 2017 Apr 21;35(12):1288-1296. Epub 2017 Feb 21.

James Chih-Hsin Yang and Chia-Chi Lin, National Taiwan University Hospital, Taipei; Wu-Chou Su, National Cheng Kung University Hospital, Tainan, Taiwan, Republic of China; Myung-Ju Ahn, Sungkyunkwan University; Dong-Wan Kim, Seoul National University Hospital; Sang-We Kim, Asan Medical Center, Seoul; Joo-Hang Kim, CHA University, Gyeonggi-do, Republic of Korea; Suresh S. Ramalingam, Emory University School of Medicine, Atlanta, GA; Lecia V. Sequist, Massachusetts General Hospital; Pasi A. Jänne, Dana-Farber Cancer Institute, Boston, MA; David Planchard, Institut Gustave Roussy, Villejuif, France; Enriqueta Felip, Vall d'Hebron University Hospital, Barcelona, Spain; Fiona Blackhall, The Christie Hospital; University of Manchester, Manchester; Helen Mann and Serban Ghiorghiu, AstraZeneca, Cambridge; Mireille Cantarini, AstraZeneca, Macclesfield, United Kingdom; Daniel Haggstrom, Carolinas Healthcare System, Charlotte, NC; Kiyotaka Yoh, National Cancer Center Hospital East, Kashiwa, Chiba; Tomonori Hirashima, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Osaka, Japan; Silvia Novello, University of Turin, Turin, Italy; and Kathryn Gold, University of California San Diego Moores Cancer Center, San Diego, CA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.70.3223
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.70.3223DOI Listing
April 2017

Prognostic Factor Analysis in Patients With Small-Cell Lung Cancer Treated With Third-Line Chemotherapy.

Clin Lung Cancer 2016 11 16;17(6):581-587. Epub 2016 Jun 16.

Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.05.022DOI Listing
November 2016

Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations.

Clin Lung Cancer 2016 09 5;17(5):412-418. Epub 2016 Feb 5.

Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Juntendo University Graduate School of Medicine, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.01.006DOI Listing
September 2016

Factors influencing the concordance of histological subtype diagnosis from biopsy and resected specimens of lung adenocarcinoma.

Lung Cancer 2016 Apr 22;94:1-6. Epub 2016 Jan 22.

Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.01.009DOI Listing
April 2016

Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinoma.

J Cancer Res Clin Oncol 2016 Mar 31;142(3):593-600. Epub 2015 Oct 31.

Division of Pathology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-015-2068-1DOI Listing
March 2016

A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer.

Med Oncol 2016 Jan 24;33(1). Epub 2015 Nov 24.

Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, 1180 Nakgasone-cho, Kita-ku, Sakai City, Osaka, 591-8555, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-015-0715-7DOI Listing
January 2016

Phase I study of nintedanib in combination with pemetrexed as second-line treatment of Japanese patients with advanced non-small cell lung cancer.

Cancer Chemother Pharmacol 2015 Dec 11;76(6):1225-33. Epub 2015 Nov 11.

Department of Medical Oncology, Kinki University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-Sayama, Osaka, 589-8511, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2896-3DOI Listing
December 2015

RECIST progression patterns during EGFR tyrosine kinase inhibitor treatment of advanced non-small cell lung cancer patients harboring an EGFR mutation.

Lung Cancer 2015 Dec 9;90(3):477-83. Epub 2015 Oct 9.

Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.09.025DOI Listing
December 2015

Phase II study of amrubicin at a dose of 45 mg/m2 in patients with previously treated small-cell lung cancer.

Jpn J Clin Oncol 2015 Oct 31;45(10):941-6. Epub 2015 Jul 31.

Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyv107DOI Listing
October 2015

Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung.

J Cancer Res Clin Oncol 2015 Aug 9;141(8):1417-25. Epub 2015 Jan 9.

Pathology Division, Department of Pathology, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, 277-8577, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00432-015-1912-7
Publisher Site
http://dx.doi.org/10.1007/s00432-015-1912-7DOI Listing
August 2015

Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy.

J Cancer Res Clin Oncol 2015 Jul 2;141(7):1163-70. Epub 2014 Dec 2.

Pathology Division, Department of Pathology, Research Center for Innovative Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-014-1891-0DOI Listing
July 2015

Docetaxel for platinum-refractory advanced thymic carcinoma.

Jpn J Clin Oncol 2015 Jul 2;45(7):665-9. Epub 2015 Apr 2.

Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyv046DOI Listing
July 2015

Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia.

Cancer Chemother Pharmacol 2015 Jul 15;76(1):69-74. Epub 2015 May 15.

Department of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-015-2775-y
Publisher Site
http://dx.doi.org/10.1007/s00280-015-2775-yDOI Listing
July 2015

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer.

Transl Lung Cancer Res 2015 Apr;4(2):156-64

1 Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan ; 2 Division of Translational Research, Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo and Chiba, Japan ; 3 Division of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan ; 4 Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2014.11.11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384213PMC
April 2015

Vinorelbine and cisplatin in patients with advanced non-small cell lung cancer with interstitial pneumonia.

Anticancer Res 2015 Mar;35(3):1697-701

Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

View Article

Download full-text PDF

Source
March 2015

Low-dose irinotecan as a second-line chemotherapy for recurrent small cell lung cancer.

Jpn J Clin Oncol 2014 Sep 23;44(9):846-51. Epub 2014 Jul 23.

Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyu094DOI Listing
September 2014

Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis.

J Thorac Oncol 2014 Sep;9(9):1324-31

*Division of Thoracic Oncology, National Cancer Center Hospital East; †Exploratory Oncology Research and Clinical Trial Center, National Cancer Center; ‡Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East; §Division of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan; and ‖Division of Genome Biology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000250DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154841PMC
September 2014

[Maintenance therapy for advanced non-small-cell lung cancer].

Gan To Kagaku Ryoho 2014 Aug;41(8):926-31

Division of Thoracic Oncology, National Cancer Center Hospital East.

View Article

Download full-text PDF

Source
August 2014

Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: a retrospective study.

Jpn J Clin Oncol 2014 Apr 5;44(4):346-54. Epub 2014 Feb 5.

*Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
https://academic.oup.com/jjco/article-lookup/doi/10.1093/jjc
Publisher Site
http://dx.doi.org/10.1093/jjco/hyu004DOI Listing
April 2014

Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: identification of prognostic microenvironmental factors after chemoradiation.

Pathol Int 2013 Dec;63(12):599-606

Division of Pathology, Research Center for Innovative Oncology, National Cancer Center, Hospital East, Kashiwa, Chiba, Japan; Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Juntendo University Graduate School of Medicine, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pin.12122DOI Listing
December 2013

RET fusion gene: translation to personalized lung cancer therapy.

Cancer Sci 2013 Nov 1;104(11):1396-400. Epub 2013 Oct 1.

Division of Translational Research, Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Japan; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439108PMC
November 2013

Identification of prognostic immunophenotypic features in cancer stromal cells of high-grade neuroendocrine carcinomas of the lung.

J Cancer Res Clin Oncol 2013 Nov 7;139(11):1869-78. Epub 2013 Sep 7.

Pathology Division, Department of Pathology, Research Center for Innovative Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa-City, Chiba, 277-8577, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00432-013-1502
Web Search
http://link.springer.com/10.1007/s00432-013-1502-5
Publisher Site
http://dx.doi.org/10.1007/s00432-013-1502-5DOI Listing
November 2013

Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinoma.

J Cancer Res Clin Oncol 2013 Oct 22;139(10):1691-700. Epub 2013 Aug 22.

Division of Pathology, Research Center for Innovative Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00432-013-1495
Web Search
http://link.springer.com/10.1007/s00432-013-1495-0
Publisher Site
http://dx.doi.org/10.1007/s00432-013-1495-0DOI Listing
October 2013

Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo.

Cancer Sci 2013 Jul 12;104(7):896-903. Epub 2013 May 12.

Division of Translational Research, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12175DOI Listing
July 2013

Renal toxicity caused by brand-name versus generic cisplatin: a comparative analysis.

Jpn J Clin Oncol 2013 Apr 26;43(4):390-5. Epub 2013 Feb 26.

Division of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyt020DOI Listing
April 2013

Safety and efficacy of platinum agents plus etoposide for patients with small cell lung cancer with interstitial lung disease.

Anticancer Res 2013 Mar;33(3):1175-9

Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
March 2013

Feasibility study of zoledronic acid plus cisplatin-docetaxel as first-line treatment for advanced non-small cell lung cancer with bone metastases.

Anticancer Res 2012 Sep;32(9):4131-5

Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
September 2012

Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung.

Lung Cancer 2012 Jun 6;76(3):423-30. Epub 2011 Dec 6.

Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2011.11.010DOI Listing
June 2012

Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.

Lung Cancer 2012 Mar 13;75(3):368-73. Epub 2011 Sep 13.

Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2011.08.012DOI Listing
March 2012

Risk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapy.

BMC Cancer 2012 Jan 20;12:27. Epub 2012 Jan 20.

Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-12-27DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293744PMC
January 2012

Development of Cushing's syndrome during effective chemotherapy for small cell lung cancer.

Intern Med 2011 15;50(4):335-8. Epub 2011 Feb 15.

Thoracic Oncology Division, National Cancer Center Hospital East, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.50.4127DOI Listing
June 2011

Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis.

J Thorac Oncol 2011 Apr;6(4):796-800

Division of Thoracic Oncology and †Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318208ec77DOI Listing
April 2011

Re-challenge chemotherapy for relapsed non-small-cell lung cancer.

Lung Cancer 2010 Sep 13;69(3):315-8. Epub 2010 Jan 13.

Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2009.11.016DOI Listing
September 2010

Severe interstitial lung disease associated with amrubicin treatment.

J Thorac Oncol 2010 Sep;5(9):1435-8

Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181e369a8DOI Listing
September 2010

Hypertrophic pulmonary osteoarthropathy as a paraneoplastic manifestation of lung cancer.

J Thorac Oncol 2010 Jul;5(7):976-80

Department of Internal Medicine 3, Oita University Faculty of Medicine, Yufu City, Oita, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181dc1f3cDOI Listing
July 2010

Trends in chemotherapy for elderly patients with advanced non-small-cell lung cancer.

Respir Med 2010 Mar 12;104(3):434-9. Epub 2009 Nov 12.

Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2009.10.020DOI Listing
March 2010

A phase I study of gemcitabine and carboplatin in patients with advanced non-small cell lung cancer and a performance status of 2.

Jpn J Clin Oncol 2009 Sep 11;39(9):576-81. Epub 2009 Jun 11.

Division of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyp061DOI Listing
September 2009

Mutational status of EGFR and KIT in thymoma and thymic carcinoma.

Lung Cancer 2008 Dec 29;62(3):316-20. Epub 2008 Apr 29.

Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2008.03.013DOI Listing
December 2008

Clinical outcome of chemoradiation therapy in patients with limited-disease small cell lung cancer with ipsilateral pleural effusion.

J Thorac Oncol 2008 Jul;3(7):723-7

Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31817c606aDOI Listing
July 2008

Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy.

Lung Cancer 2007 Oct 4;58(1):73-9. Epub 2007 Jun 4.

Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016950020700262
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2007.04.015DOI Listing
October 2007

Detection of unsuspected distant metastases and/or regional nodes by FDG-PET [corrected] scan in apparent limited-disease small-cell lung cancer.

Lung Cancer 2007 Sep 29;57(3):328-33. Epub 2007 May 29.

Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwanoha 6-5-1, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2007.04.001DOI Listing
September 2007

Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity.

Lung Cancer 2007 Mar 28;55(3):337-41. Epub 2006 Nov 28.

Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2006.10.016DOI Listing
March 2007

Eg5 expression is closely correlated with the response of advanced non-small cell lung cancer to antimitotic agents combined with platinum chemotherapy.

Lung Cancer 2006 Nov 24;54(2):217-25. Epub 2006 Aug 24.

Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2006.06.018DOI Listing
November 2006

Interstitial shadow on chest CT is associated with the onset of interstitial lung disease caused by chemotherapeutic drugs.

Jpn J Clin Oncol 2006 May 15;36(5):269-73. Epub 2006 May 15.

Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwanoha 6-5-1, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
https://academic.oup.com/jjco/article-lookup/doi/10.1093/jjc
Publisher Site
http://dx.doi.org/10.1093/jjco/hyl021DOI Listing
May 2006

First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer: a phase II study.

J Clin Oncol 2006 Jan;24(1):64-9

Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.02.5825DOI Listing
January 2006

High body mass index correlates with increased risk of venous irritation by vinorelbine infusion.

Jpn J Clin Oncol 2004 Apr;34(4):206-9

Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyh029DOI Listing
April 2004

Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma.

Cancer 2003 Sep;98(5):926-31

Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.11606DOI Listing
September 2003

Cushing's syndrome associated with adenocarcinoma of the lung.

Intern Med 2003 Sep;42(9):831-3

Thoracic Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.42.831DOI Listing
September 2003

[New treatment strategy for stage III non-small-cell lung cancer].

Nihon Rinsho 2002 May;60 Suppl 5:485-9

Thoracic Oncology Division, National Cancer Center Hospital East.

View Article

Download full-text PDF

Source
May 2002